|
1
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Lambert R, Sauvaget C and Sankaranarayanan
R: Mass screening for colorectal cancer is not justified in most
developing countries. Int J Cancer. 125:253–256. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Anderson BO, Shyyan R, Eniu A, et al:
Breast cancer in limited-resource countries: An overview of the
Breast Health Global Initiative 2005 Guidelines. Breast J. 12(Suppl
1): S3–S15. 2006.PubMed/NCBI
|
|
4
|
Gottesman MM: Mechanisms of cancer drug
resistance. Annu Rev Med. 53:615–627. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Efferth T, Li PC, Konkimalla VS and Kaina
B: From traditional Chinese medicine to rational cancer therapy.
Trends Mol Med. 13:353–361. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chatterjee S, Kundu S and Bhattacharyya A:
Mechanism of cadmium induced apoptosis in the immunocyte. Toxicol
Lett. 177:83–89. 2008. View Article : Google Scholar
|
|
7
|
Pathak N and Khandelwal S: Role of
oxidative stress and apoptosis in cadmium induced thymic atrophy
and splenomegaly in mice. Toxicol Lett. 169:95–108. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gupta S, Yel L, Kim D, et al: Arsenic
trioxide induces apoptosis in peripheral blood T lymphocyte subsets
by inducing oxidative stress: a role of Bcl-2. Mol Cancer Ther.
2:711–719. 2003.PubMed/NCBI
|
|
9
|
Fan TJ, Han LH, Cong RS, et al: Caspase
family proteases and apoptosis. Acta Biochim Biophys Sin
(Shanghai). 37:719–727. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Reed JC: Mechanisms of apoptosis. Am J
Pathol. 157:1415–1430. 2000. View Article : Google Scholar
|
|
11
|
Ghobrial IM, Witzig TE and Adjei AA:
Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin.
55:178–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Desagher S and Martinou JC: Mitochondria
as the central control point of apoptosis. Trends Cell Biol.
10:369–377. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li H, Zhu H, Xu CJ and Yuan J: Cleavage of
BID by caspase 8 mediates the mitochondrial damage in the Fas
pathway of apoptosis. Cell. 94:491–501. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Green D and Kroemer G: The central
executioners of apoptosis: caspases or mitochondria? Trends Cell
Biol. 8:267–271. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Moalic S, Liagre B, Corbière C, et al: A
plant steroid, diosgenin, induces apoptosis, cell cycle arrest and
COX activity in osteosarcoma cells. FEBS Lett. 506:225–230. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kaskiw MJ, Tassotto ML, Th'ng J and Jiang
ZH: Synthesis and cytotoxic activity of diosgenyl saponin
analogues. Bioorgan Med Chem. 16:3209–3217. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kaskiw MJ, Tassotto ML, Mok M, et al:
Structural analogues of diosgenyl saponins: synthesis and
anticancer activity. Bioorgan Med Chem. 17:7670–7679. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu MJ, Yue PY, Wang Z and Wong RN: Methyl
protodioscin induces G2/M arrest and apoptosis in K562 cells with
the hyperpolarization of mitochondria. Cancer Lett. 224:229–241.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tong QY, Qing Y, Shu D, et al: Deltonin, a
steroidal saponin, inhibits colon cancer cell growth in vitro and
tumor growth in vivo via induction of apoptosis and
antiangiogenesis. Cell Physiol Biochem. 27:233–242. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shu D, Qing Y, Tong QY, et al: Deltonin
isolated from Dioscorea zingiberensis inhibits cancer cell
growth through inducing mitochondrial apoptosis and suppressing AKT
and mitogen activated protein kinase signals. Biol Pharml Bull.
34:1231–1239. 2011.
|
|
21
|
Moon DO, Choi YH, Moon SK, et al: Gossypol
decreases tumor necrosis factor-α-induced intercellular adhesion
molecule-1 expression via suppression of NF-κB activity. Food Chem
Toxicol. 49:999–1005. 2011.PubMed/NCBI
|
|
22
|
Zhang Z, Li M, Wang H, et al: Antisense
therapy targeting MDM2 oncogene in prostate cancer: effects on
proliferation, apoptosis, multiple gene expression and
chemotherapy. Proc Natl Acad Sci USA. 100:11636–11641. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Edwards LA, Thiessen B, Dragowska WH, et
al: Inhibition of ILK in PTEN-mutant human glioblastomas inhibits
PKB/Akt activation, induces apoptosis and delays tumor growth.
Oncogene. 24:3596–3605. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cossarizza A, Baccarani-Contri M,
Kalashnikova G and Franceschi C: A new method for the
cytofluorimetric analysis of mitochondrial membrane potential using
the J-aggregate forming lipophilic cation
5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine
iodide (JC-1). Biochem Biophys Res Commun. 197:40–45.
1993.PubMed/NCBI
|
|
25
|
Kroemer G, Zamzami N and Susin SA:
Mitochondrial control of apoptosis. Immunol Today. 18:44–51. 1997.
View Article : Google Scholar
|
|
26
|
Mitsopoulos P and Suntres ZE: Protective
effects of liposomal N-Acetylcysteine against paraquat-induced
cytotoxicity and gene expression. J Toxicol. 2011:1–14. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Konopleva M, Contractor R, Tsao T, et al:
Mechanisms of apoptosis sensitivity and resistance to the BH3
mimetic ABT-737 in acute myeloid leukemia. Cancer Cell. 10:375–388.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nguyen TT, Tran E, Nguyen TH, et al: The
role of activated MEK-ERK pathway in quercetin-induced growth
inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis.
25:647–659. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cusimano A, Foderà D, D'Alessandro N, et
al: Potentiation of the antitumor effects of both selective
cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic
cancer cells by inhibition of the MEK/ERK pathway. Cancer Biother.
6:1461–1468. 2007.PubMed/NCBI
|
|
30
|
Kunnimalaiyaan M, Ndiaye M and Chen H:
Apoptosis-mediated medullary thyroid cancer growth suppression by
the PI3K inhibitor LY294002. Surgery. 140:1009–1014. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kong CS, Kimb JA, Yoon NY and Kim SK:
Induction of apoptosis by phloroglucinol derivative from
Ecklonia cava in MCF-7 human breast cancer cells. Food Chem
Toxicol. 47:1653–1658. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Haruna S, Kuroi R, Kajiwara K, Hashimoto
R, Matsugo S, Tokumaruc S and Kojoa S: Induction of apoptosis in
HL-60 cells by photochemically generated hydroxyl radicals.
Bioorgan Med Chem Lett. 12:675–676. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu H, Xiao Y, Xiong C, Wei A and Ruan J:
Apoptosis induced by a new flavonoid in human hepatoma HepG2 cells
involves reactive oxygen species-mediated mitochondrial dysfunction
and MAPK activation. Eur J Pharmacol. 654:209–216. 2011. View Article : Google Scholar
|
|
34
|
Kim MJ, Liao J, Dowling ML, et al: TRAIL
inactivates the mitotic checkpoint and potentiates death induced by
microtubule-targeting agents in human cancer cells. Cancer Res.
68:3440–3449. 2008. View Article : Google Scholar
|
|
35
|
Danial NN and Korsmeyer SJ: Cell death:
critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kluck RM, Bossy-Wetzel E, Green DR and
Newmeyer DD: The release of cytochrome c from mitochondria: a
primary site for Bcl-2 regulation of apoptosis. Science.
275:1132–1136. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Monteghirfo S, Tosetti F, Ambrosini C, et
al: Antileukemia effects of xanthohumol in Bcr/Abl-transformed
cells involve nuclear factor-kappaB and p53 modulation. Mol Cancer
Ther. 7:2692–2702. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Won SJ, Chung KS, Ki YS, Choi JH, Cho WJ
and Lee KT: CWJ-081, a novel 3-arylisoquinoline derivative, induces
apoptosis in human leukemia HL-60 cells partially involves reactive
oxygen species through c-Jun NH2-terminal kinase pathway. Bioorgan
Med Chem Lett. 20:6447–6451. 2010. View Article : Google Scholar
|
|
39
|
Han YM, Shin DS, Lee YJ, Ismail IA, Hong
SH, Han DC and Kwon BM: 2-Hydroxycurcuminoid induces apoptosis of
human tumor cells through the reactive oxygen species-mitochondria
pathway. Bioorgan Med Chem Lett. 21:747–751. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dillon RL, White DE and Muller WJ: The
phosphatidyl inositol 3-kinase signaling network: implications for
human breast cancer. Oncogene. 26:1338–1345. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Viglietto G, Motti ML, Bruni P, et al:
Cytoplasmic relocalization and inhibition of the cyclin-dependent
kinase inhibitor p27 (Kip1) by PKB/Akt-mediated phosphorylation in
breast cancer. Nat Med. 8:1136–1144. 2002. View Article : Google Scholar
|
|
42
|
Brunet A, Bonni A, Zigmond MJ, et al: AKT
promotes cell survival by phosphorylating and inhibiting a Forkhead
transcription factor. Cell. 96:857–868. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bartkova J, Lukas J, Muller H, Lutzhoft D,
Strauss M and Bartek J: Cyclin D1 protein expression and function
in human breast cancer. Int J Cancer. 57:353–361. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li Y, Corradetti MN, Inoki K and Guan KL:
TSC2: filling the GAP in the mTOR signaling pathway. Trends Biochem
Sci. 29:32–38. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-kinase-AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
46
|
Fang JY and Richardson BC: The MAPK
signaling pathways and colorectal cancer. Lancet Oncol. 6:322–327.
2005. View Article : Google Scholar : PubMed/NCBI
|
